Skip to main content
. Author manuscript; available in PMC: 2020 Oct 1.
Published in final edited form as: Eur J Pharm Sci. 2019 Aug 5;138:105032. doi: 10.1016/j.ejps.2019.105032

Table 2.

Model parameter values for the systems PK/PD model in humans, monkeys, and rabbits

Parameter Unit Humans Monkeys Rabbits
Physiological parameters
Body weight kg 70 3.5 2.9
Vp L 2.6 (Cao et al., 2013) 0.157 (Zhao et al., 2015) 0.107 (Armin et al., 1952)
Visf L 15.6 (Cao et al., 2013) 0.735 (Zhao et al., 2015) 0.764 (Pavlin et al., 1986)
Kp - 0.4 (Cao et al., 2013)
Vl L 5.2 (Cao et al., 2013) a 0.314 (Zhao et al., 2015) a 0.153 (Armin et al., 1952)
L L·day−1 2.904 (Cao et al., 2013) 0.288 (Zhao et al., 2015) 0.144 (Zhao et al., 2015)
σ1 - 0.945 (Cao et al., 2013)
σ2 - 0.697 (Cao et al., 2013)
σl - 0.2 (Cao et al., 2013)
Target parameters
kon M−1·s−1 4.48×106 (Hilden et al., 2012)
koff s−1 b 1.74×10−3
sTFPI_b nM 1.6 (Hansen et al., 2014) 0.91 (Gu et al., 2017) 1.4 (Hansen et al., 2014)
kdegs day−1 1.18 (Farrokhi et al., 2018) c 2.50 c 2.62
mTFPI_b nM b 20.03 d 11.32 d 17.50
kdegm/kint day−1 b 1.155 c 2.44 c 2.56
Endosome parameters
CLup L·day−1 1.48 (Yuan et al., 2018) e 0.045 e 0.0672
krec day−1 124.7 (Hopkins and Trowbridge, 1983)
CLe L·day−1 5.75 (Yuan et al., 2018) c 0.61 c 0.53
Ve1 L f 0.005% of body weight (Li et al., 2014)
Ve2 L
FcRn_b nM 49800 (Shah and Betts, 2012)
k1on M−1·s−1 g 2.41×105
k1off s−1 g 0.162
SC absorption parameters
F - h 0.93 0.93 (Agerso et al., 2014) -
ka day−1 h 0231 0.231 (Agerso et al., 2014) -
a

Assume equal to blood volume (Cao et al., 2013);

b

Optimized in the reduced PK/PD model;

c

Scaled from human value using a scaling factor of −0.25 for rate constant and 0.75 for clearance based on body weight;

d

sTFPI and mTFPI are produced through alternative splicing of the same TFPI gene (Maroney et al., 2010). Based on the sTFPI baseline, monkeys and rabbits were calculated as human mTFPI_b×animal sTFPI_bhuman sTFPI_b;

e

Optimized using PK data of antibodies that show linear clearance (Figure 4);

f

Assume the volume of endosome is 1% of cell volume and the total endothelial cell volume is 0.5% of total tissue volume (Li et al., 2014);

g

Assume equal to the binding affinity of adalimumab, a wild-type IgG1, to human FcRn (Suzuki et al., 2010). The IgG isotype has a negligible influence on FcRn binding (Neuber et al., 2014; Vidarsson et al., 2014). Monkey FcRn and rabbit FcRn have been shown to bind human IgG with similar affinity as human FcRn (Szikora et al., 2017; Yeung et al., 2010);

h

Assume equal to monkey value.